Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/22/2025

Magnesium Deficiency Risk in PPI Users

Mechanism and Risk Profile

  • PPIs reduce gastric acid production, which impairs magnesium absorption in the gastrointestinal tract, as noted by the Annual Review of Nutrition 1
  • Meta-analysis data shows PPI users have a 71% higher risk of hypomagnesemia (adjusted OR: 1.71; 95% CI: 1.33, 2.19) compared to non-users, according to the Annual Review of Nutrition 2, 3
  • A dose-dependent effect is observed, with higher PPI doses (>1.5 pills/day) showing stronger associations with magnesium deficiency, as reported by the Annual Review of Nutrition 1

Clinical Significance and Symptoms

  • No cited facts are available for this section

Evidence Quality and Guideline Recommendations

  • The American Gastroenterological Association does not currently recommend routine screening for magnesium or other nutrients in PPI users, citing lack of causal evidence and heterogeneous findings, as stated in the Annual Review of Nutrition 2
  • RCT data is less conclusive, with large trials comparing PPIs to surgery or placebo for up to 5 years showing no significant differences in magnesium levels, as noted by the Annual Review of Nutrition 2

Practical Monitoring Algorithm

  • In high-risk populations, such as patients on concurrent diuretics, elderly patients (≥60 years), those with renal insufficiency, or patients with malabsorption syndromes, magnesium levels should be monitored, according to Gut 4, 5
  • Consider switching to alternative treatments (H2 blockers, dietary modifications, or topical steroids for eosinophilic esophagitis) if magnesium deficiency is clearly PPI-related, as suggested by Gut 4

Critical Pitfalls to Avoid

  • Don't assume normal serum magnesium excludes deficiency, as serum levels represent <1% of total body magnesium and may not accurately reflect total body stores, as noted by a non-Praxis Medical Insights source is not available, however, Gut suggests multifactorial causes should be considered 4, 5
  • Don't overlook multifactorial causes, such as concurrent diuretic use, renal losses, or malabsorption, requiring individualized assessment, as reported by Gut 4, 5

Conflicting Evidence Considerations

  • The preponderance of evidence from case series, meta-analyses, and FDA postmarketing surveillance supports the association between PPI use and hypomagnesemia, particularly with long-term use, as noted by the Annual Review of Nutrition 2, 3, 7